Open menu
Markets
Currencies
Cryptocurrencies
Commodities
Nigeria SE
Rwanda SE
Nairobi SE
JSE Top 40
News
Regions
CNBC TV
Insights
Markets
Currencies
Cryptocurrencies
Commodities
Nigeria SE
Rwanda SE
Nairobi SE
JSE Top 40
News
Latest
Featured
Cryptocurrency
Economy
Special Reports
Technology
Trade
Climate Change
Markets
Newswire
Regions
Southern Africa
West Africa
East Africa
International
CNBC TV
Latest Video
Top Video
Watch Live
Earnings
CEO Interviews
Analysis
TV Guide
Insights
AFCFTA
Debates
Sponsored
Opinion
Watch Live
Open menu
Markets
News
Regions
CNBC TV
Insights
aspen
WHO, Gavi not planning COVID vaccine buys from S.Africa’s Aspen
Reuters
•
Mon, May 9th 2022
Africa CDC urges COVID-19 vaccine buyers to order from S.Africa’s Aspen
Reuters
•
Thu, May 5th 2022
DFIs extend 600mn euro joint financing package to Aspen
CNBC Africa
•
Wed, Jun 30th 2021
Aspen CEO discusses H1 results, J&J vaccine production & COVID-19 legacy
CNBC Africa
•
Mon, Mar 15th 2021
Aspen Chair warns against hogging of COVID-19 vaccines by rich nations
CNBC Africa
•
Tue, Feb 2nd 2021
Aspen agrees deal to manufacture Johnson & Johnson’s Covid-19 vaccine candidate
CNBC Africa
•
Thu, Nov 5th 2020
Aspen FY revenue up 9% to R38.6bn
CNBC Africa
•
Thu, Sep 10th 2020
South African drugmaker Aspen expects 7-11% full-year earnings growth
Reuters
•
Thu, Aug 27th 2020
Aspen offers to cut cancer drug prices, may avoid EU antitrust fine
Reuters
•
Tue, Jul 14th 2020
Aspen CEO on the availability of breakthrough coronavirus drug in South Africa
CNBC Africa
•
Wed, Jun 17th 2020
Stephen Saad on the impact of COVID-19 on Aspen
CNBC Africa
•
Fri, Mar 6th 2020
Nampak CEO puts paid to investors’ debt concerns
CNBC Africa
•
Fri, Jul 26th 2019
Glass half full for Nampak
CNBC Africa
•
Fri, Jul 26th 2019